Question
What are the issues raised by patenting of onco-mouse?
Answer :
Word Count : 956
The patenting of the onco-mouse, a genetically engineered mouse developed by Harvard University in the 1980s for cancer research, raised a wide range of legal, ethical, economic, and social issues within the framework of intellectual property rights management. The onco-mouse was designed to carry a gene that made it highly susceptible to cancer, thereby serving as a valuable tool for studying tumor development and testing treatments. While it represented a breakthrough in biotechnology, its patenting sparked global debates about the limits and implications of granting proprietary rights over living organisms. One of the central issues concerns the ethical implications of patenting life forms. The onco-mouse is not a mechanical invention but a living being capable of suffering, reproduction, and biological processes. Critics argue that granting patents over such organisms commodifies life and reduces living entities to mere objects of ownership and commercial exploitation. This raises moral questions about whether humans have the right to claim ownership over genetically modified ________ ____ ________ __________ __________ ______.
____ ________ ____ ___ _______ ______ ____.
_________ ________ __________ __________ _____ __________ _______ _______ _______.
__________ _________ _________ ________ ___.
_________ ______ ________ ________ _________ _________ ___ ____ __________ __________ ________ ____.
_________ ________ _______ _________ _____ ___ ____ _______.
_________ ______ _________ _________ ______ ________.
_____ _________ _____ ______ ___ ___ ___ _____ __________ ________ _______.
______ ____ ______ ___ ____ _________ _________ _______.
___ ________ _______ ___ _____ __________ ________ ___ __________ _________ __________ _____.
_______ _________ ______ _________ __________ _______ ___ _________ __________ ___.
______ _________ __________ ________ ______ ______ _____ _________ __________ __________ ___.
__________ __________ ____ ______ ___ ______ _______ __________ __________.
___ _______ _____ ______ ______ _____ _____ __________ __________.
_______ ______ _________ ______ __________ _____ ______.
___ _________ _____ _________ _______ ___ _______ ________ ____ _______ _____ __________.
____ _______ __________ ___ ______.
____ ________ ____ _________ __________ __________ _________ ____ ________.
________ ________ ________ _____ _________ ______ _________.
____ __________ ____ _________ ______ ___ _______.
___ _____ ______ ____ _______ _________ __________.
___ ______ ____ ____ ___ ____ ___ __________ ________ _____ ____ ______.
_______ ___ _______ ___ _________ ______.
____ _________ __________ _______ ______ _____ ______ _______ ____ __________ _______.
__________ _______ ________ ________ _________ _____ _________ _____ _____ __________.
_____ _________ ____ ___ _____ ______ _____ ______.
___ __________ __________ _______ _____ ___ ______ _____.
__________ _________ ___ ________ __________.
_______ __________ ______ ______ ______ _______ ______ __________ ____ _________ _________.
________ ____ __________ ___ ____ ____ ___.
_________ ___ _____ _________ _________ _______ _______ _______ ________ _______.
______ ___ ____ _________ _______ _________ ______ ___ ________ ____.
___ ________ ____ ___ _____ ______ ________ _____.
_______ _____ ______ __________ ____ ______.
______ ____ _________ ______ ___ ______.
___ __________ ___ ________ ____ _______ _________ ______ _____ ____ ______.
_____ __________ ____ _______ _____.
___ _______ ____ ______ __________ ____ ____ ______ _______ __________ ___.
________ ______ _____ ______ _______ __________ _______.
____ __________ __________ _______ _____ ________ ____ ____ ______ ________.
___ _____ _______ _______ _______ ____ _______ ______ _______ ________.
________ ____ ___ ____ ________ ________.
____ _________ __________ _______ ___ _____ ____.
_________ ________ ___ __________ ___ _______ __________ _________.
__________ __________ _____ ___ _______ _____ _____.
_________ ___ __________ __________ ____ ___ ______.
______ ______ ___ _____ ________ ________.
_____ _________ ___ __________ ______ ____ _____ ________ _____ ______ _____.
______ _________ _______ _____ ___ ____ ________ _________ ___.
___ ___ _________ __________ _________.
__________ __________ ___ __________ _________ _______ ____ ______ ____.
____ _____ _______ ___ ________ _______ ___ _________ __________ ______.
______ ______ __________ ________ _____ ___ _______ _________ _________ _________.
________ ____ _____ _______ _________.
_______ _______ _______ ______ ____ _______ _________ ______ ___ ___.
_____ _________ ________ _____ __________ ____ __________ _____ ______.
______ ________ ___ ______ _________ _________ ____ _______ _________.
__________ _________ ______ ______ ________ ______ _____ __________.
___ __________ ________ __________ ____.
_______ _______ __________ ________ _____ _______ ______ _________ __________ __________.
_________ _____ ____ _____ ___ ______ _____.
__________ _________ _____ ___ _____.
_____ _______ ______ ______ _____ ________ ___.
_____ _____ __________ _____ _________ _____ __________ ________ ______ ______.
______ _____ ______ ___ _______ ____.
_______ ___ _______ _________ _______ _____ _______ __________ ___.
_______ ___ __________ _____ ____ ________ __________ __________ ____.
__________ ___ _____ __________ ________ _________.
___ __________ ________ ___ _______ _________ ___ _____ ___ ______.
___ _______ ___ ___ ___ ________ ________ ________ ___.
_______ _________ _______ _________ __________ _____ _______ ___ __________ ____.
________ ________ ________ __________ _______ ________ _________ _______ _______ _____ ____ ________.
____ _______ ____ _____ ___ _________ _________.
_________ ______ __________ _________ ______ __________ _____.
________ _______ _____ ______ __________ ______ _______.
__________ ________ _________ _______ ________ ____ __________ _______ __________.
___ ________ ___ __________ ___ _______.
____ _________ ______ __________ _____.
__________ ___ ________ _______ _________ __________ ___ _________ ________ _____ _____.
____ ___ ___ _____ ________ ___ _______.
_____ ___ ____ ___ ________ _____.
_______ _____ ________ __________ __________ __________ _____ __________ _________ ___.
___ _________ ________ _____ ____ _________ ___.
_______ _____ _______ _________ __________ __________ ______ ____.
____ __________ ________ _____ _________ __________ ________ ______ __________ _____.
__________ ____ ______ _______ ___ ________ _________ ______ _______.
________ _____ ______ ____ ____ ______ _________ ________ _________ _____.
_______ ________ ______ __________ _____ ______ _______.
_________ __________ ____ ________ ______ ____ ________ _________ _____.
__________ _____ _______ _____ _________ _______ ___ ______ ___ _________ ____ ______.
_____ ___ ____ _________ __________ _______ ___.
___ ________ ____ _________ ________ __________ ________ ____ _____ _______ ____ ______.
_________ _________ _____ ___ __________ _______ ________ __________ _________ ____ ________ ________.
_____ ________ ___ __________ ____ _______ _________ _____ _________ ______ __________.
__________ ______ ______ _______ __________ _____ ________.
________.
Get Full Answer on WhatsApp
The patenting of the onco-mouse, a genetically engineered mouse developed by Harvard University in the 1980s for cancer research, raised a wide range of legal, ethical, economic, and social issues within the framework of intellectual property rights management. The onco-mouse was designed to carry a gene that made it highly susceptible to cancer, thereby serving as a valuable tool for studying tumor development and testing treatments. While it represented a breakthrough in biotechnology, its patenting sparked global debates about the limits and implications of granting proprietary rights over living organisms. One of the central issues concerns the ethical implications of patenting life forms. The onco-mouse is not a mechanical invention but a living being capable of suffering, reproduction, and biological processes. Critics argue that granting patents over such organisms commodifies life and reduces living entities to mere objects of ownership and commercial exploitation. This raises moral questions about whether humans have the right to claim ownership over genetically modified ________ ____ ________ __________ __________ ______.
____ ________ ____ ___ _______ ______ ____.
_________ ________ __________ __________ _____ __________ _______ _______ _______.
__________ _________ _________ ________ ___.
_________ ______ ________ ________ _________ _________ ___ ____ __________ __________ ________ ____.
_________ ________ _______ _________ _____ ___ ____ _______.
_________ ______ _________ _________ ______ ________.
_____ _________ _____ ______ ___ ___ ___ _____ __________ ________ _______.
______ ____ ______ ___ ____ _________ _________ _______.
___ ________ _______ ___ _____ __________ ________ ___ __________ _________ __________ _____.
_______ _________ ______ _________ __________ _______ ___ _________ __________ ___.
______ _________ __________ ________ ______ ______ _____ _________ __________ __________ ___.
__________ __________ ____ ______ ___ ______ _______ __________ __________.
___ _______ _____ ______ ______ _____ _____ __________ __________.
_______ ______ _________ ______ __________ _____ ______.
___ _________ _____ _________ _______ ___ _______ ________ ____ _______ _____ __________.
____ _______ __________ ___ ______.
____ ________ ____ _________ __________ __________ _________ ____ ________.
________ ________ ________ _____ _________ ______ _________.
____ __________ ____ _________ ______ ___ _______.
___ _____ ______ ____ _______ _________ __________.
___ ______ ____ ____ ___ ____ ___ __________ ________ _____ ____ ______.
_______ ___ _______ ___ _________ ______.
____ _________ __________ _______ ______ _____ ______ _______ ____ __________ _______.
__________ _______ ________ ________ _________ _____ _________ _____ _____ __________.
_____ _________ ____ ___ _____ ______ _____ ______.
___ __________ __________ _______ _____ ___ ______ _____.
__________ _________ ___ ________ __________.
_______ __________ ______ ______ ______ _______ ______ __________ ____ _________ _________.
________ ____ __________ ___ ____ ____ ___.
_________ ___ _____ _________ _________ _______ _______ _______ ________ _______.
______ ___ ____ _________ _______ _________ ______ ___ ________ ____.
___ ________ ____ ___ _____ ______ ________ _____.
_______ _____ ______ __________ ____ ______.
______ ____ _________ ______ ___ ______.
___ __________ ___ ________ ____ _______ _________ ______ _____ ____ ______.
_____ __________ ____ _______ _____.
___ _______ ____ ______ __________ ____ ____ ______ _______ __________ ___.
________ ______ _____ ______ _______ __________ _______.
____ __________ __________ _______ _____ ________ ____ ____ ______ ________.
___ _____ _______ _______ _______ ____ _______ ______ _______ ________.
________ ____ ___ ____ ________ ________.
____ _________ __________ _______ ___ _____ ____.
_________ ________ ___ __________ ___ _______ __________ _________.
__________ __________ _____ ___ _______ _____ _____.
_________ ___ __________ __________ ____ ___ ______.
______ ______ ___ _____ ________ ________.
_____ _________ ___ __________ ______ ____ _____ ________ _____ ______ _____.
______ _________ _______ _____ ___ ____ ________ _________ ___.
___ ___ _________ __________ _________.
__________ __________ ___ __________ _________ _______ ____ ______ ____.
____ _____ _______ ___ ________ _______ ___ _________ __________ ______.
______ ______ __________ ________ _____ ___ _______ _________ _________ _________.
________ ____ _____ _______ _________.
_______ _______ _______ ______ ____ _______ _________ ______ ___ ___.
_____ _________ ________ _____ __________ ____ __________ _____ ______.
______ ________ ___ ______ _________ _________ ____ _______ _________.
__________ _________ ______ ______ ________ ______ _____ __________.
___ __________ ________ __________ ____.
_______ _______ __________ ________ _____ _______ ______ _________ __________ __________.
_________ _____ ____ _____ ___ ______ _____.
__________ _________ _____ ___ _____.
_____ _______ ______ ______ _____ ________ ___.
_____ _____ __________ _____ _________ _____ __________ ________ ______ ______.
______ _____ ______ ___ _______ ____.
_______ ___ _______ _________ _______ _____ _______ __________ ___.
_______ ___ __________ _____ ____ ________ __________ __________ ____.
__________ ___ _____ __________ ________ _________.
___ __________ ________ ___ _______ _________ ___ _____ ___ ______.
___ _______ ___ ___ ___ ________ ________ ________ ___.
_______ _________ _______ _________ __________ _____ _______ ___ __________ ____.
________ ________ ________ __________ _______ ________ _________ _______ _______ _____ ____ ________.
____ _______ ____ _____ ___ _________ _________.
_________ ______ __________ _________ ______ __________ _____.
________ _______ _____ ______ __________ ______ _______.
__________ ________ _________ _______ ________ ____ __________ _______ __________.
___ ________ ___ __________ ___ _______.
____ _________ ______ __________ _____.
__________ ___ ________ _______ _________ __________ ___ _________ ________ _____ _____.
____ ___ ___ _____ ________ ___ _______.
_____ ___ ____ ___ ________ _____.
_______ _____ ________ __________ __________ __________ _____ __________ _________ ___.
___ _________ ________ _____ ____ _________ ___.
_______ _____ _______ _________ __________ __________ ______ ____.
____ __________ ________ _____ _________ __________ ________ ______ __________ _____.
__________ ____ ______ _______ ___ ________ _________ ______ _______.
________ _____ ______ ____ ____ ______ _________ ________ _________ _____.
_______ ________ ______ __________ _____ ______ _______.
_________ __________ ____ ________ ______ ____ ________ _________ _____.
__________ _____ _______ _____ _________ _______ ___ ______ ___ _________ ____ ______.
_____ ___ ____ _________ __________ _______ ___.
___ ________ ____ _________ ________ __________ ________ ____ _____ _______ ____ ______.
_________ _________ _____ ___ __________ _______ ________ __________ _________ ____ ________ ________.
_____ ________ ___ __________ ____ _______ _________ _____ _________ ______ __________.
__________ ______ ______ _______ __________ _____ ________.
________.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★